Published: Nov. 6, 2009 at 3:45 PM CHICAGO, Nov. 6 (UPI) -- The time between treatment and prostate specific antigen rise may help predict prostate cancer outcomes, U.S. researchers said. Study leader Dr. Mark Buyyounouski of...
[read full story]
powered by 